{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:41:55Z","timestamp":1790167315456,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12020-018-1531-6","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:01:18Z","timestamp":1516885278000},"page":"138-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats"],"prefix":"10.1007","volume":"60","author":[{"given":"Mostafa","family":"Shahrezaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Oryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Bastami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepanta","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Shahrezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-2786","authenticated-orcid":false,"given":"Amir","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"1","key":"1531_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1098-3597(06)80063-3","volume":"8","author":"SL Bonnick","year":"2006","unstructured":"S.L. Bonnick, Osteoporosis in men and women. Clin. Cornerstone 8(1), 28\u201339 (2006)","journal-title":"Clin. Cornerstone"},{"issue":"2","key":"1531_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11926-008-0017-6","volume":"10","author":"ZA Cole","year":"2008","unstructured":"Z.A. Cole, E.M. Dennison, C. Cooper, Osteoporosis epidemiology update. Curr. Rheumatol. Rep. 10(2), 92\u201396 (2008)","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"1531_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1211\/jpp.58.1.0002","volume":"58","author":"SB Jadhav","year":"2006","unstructured":"S.B. Jadhav, G.K. Jain, Statins and osteoporosis: new role for old drugs. J. Pharm. Pharmacol. 58(1), 3\u201318 (2006)","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"1531_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12020-016-1209-x","volume":"55","author":"RA Adler","year":"2017","unstructured":"R.A. Adler, Risk factors for osteoporosis 2000\u20132012. Endocrine 55(3), 664\u2013665 (2017)","journal-title":"Endocrine"},{"issue":"1","key":"1531_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58\u201369 (2012)","journal-title":"Endocrine"},{"issue":"7","key":"1531_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","volume":"84","author":"KA Kennel","year":"2009","unstructured":"K.A. Kennel, M.T. Drake, Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin. Proc. 84(7), 632\u2013638 (2009)","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"1531_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4184\/asj.2016.10.4.787","volume":"10","author":"KC An","year":"2016","unstructured":"K.C. An, Selective estrogen receptor modulators. Asian Spine J. 10(4), 787\u2013791 (2016)","journal-title":"Asian Spine J."},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2015.07.022","volume":"215","author":"A Oryan","year":"2015","unstructured":"A. Oryan, A. Kamali, A. Moshiri, Potential mechanisms and applications of statins on osteogenesis: current modalities, conflicts and future directions. J. Control. Release 215, 12\u201324 (2015)","journal-title":"J. Control. Release"},{"issue":"6","key":"1531_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00223-015-9981-9","volume":"96","author":"A Moshiri","year":"2015","unstructured":"A. Moshiri, M. Shahrezaee, B. Shekarchi, A. Oryan, K. Azma, Three-dimensional porous gelapin\u2013simvastatin scaffolds promoted bone defect healing in rabbits. Calcif. Tissue Int. 96(6), 552\u2013564 (2015)","journal-title":"Calcif. Tissue Int."},{"issue":"7","key":"1531_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/1440-1681.12577","volume":"43","author":"A Moshiri","year":"2016","unstructured":"A. Moshiri, A.M. Sharifi, A. Oryan, Role of simvastatin on fracture healing and osteoporosis: a systematic review on in vivo investigations. Clin. Exp. Pharmacol. Physiol. 43(7), 659\u2013684 (2016)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"1531_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1749-799X-9-18","volume":"9","author":"A Oryan","year":"2014","unstructured":"A. Oryan, S. Alidadi, A. Moshiri, N. Maffulli, Bone regenerative medicine: classic options, novel strategies, and future directions. J. Orthop. Surg. Res. 9(1), 18 (2014)","journal-title":"J. Orthop. Surg. Res."},{"issue":"2","key":"1531_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.14310\/horm.2002.1339","volume":"11","author":"AN Tsartsalis","year":"2012","unstructured":"A.N. Tsartsalis, C. Dokos, G.D. Kaiafa, D.N. Tsartsalis, A. Kattamis, A.I. Hatzitolios, C.G. Savopoulos, Statins, bone formation and osteoporosis: hope or hype. Hormone 11(2), 126\u2013139 (2012)","journal-title":"Hormone"},{"issue":"3","key":"1531_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/cc12499","volume":"17","author":"JO Jansen","year":"2013","unstructured":"J.O. Jansen, J.M. Lord, D.R. Thickett, M.J. Midwinter, D.F. McAuley, F. Gao, Clinical review: statins and trauma\u2013a systematic review. Crit. Care 17(3), 227 (2013)","journal-title":"Crit. Care"},{"issue":"4","key":"1531_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1600-0501.2011.02341.x","volume":"24","author":"Z Du","year":"2013","unstructured":"Z. Du, J. Chen, F. Yan, N. Doan, S. Ivanovski, Y. Xiao, Serum bone formation marker correlation with improved osseointegration in osteoporotic rats treated with simvastatin. Clin. Oral. Implant. Res. 24(4), 422\u2013427 (2013)","journal-title":"Clin. Oral. Implant. Res."},{"issue":"8","key":"1531_CR15","first-page":"606","volume":"66","author":"I Gradosova","year":"2011","unstructured":"I. Gradosova, H. Zivna, K. Svejkovska, V. Palicka, A. Tichy, P. Zivny, The role of atorvastatin in bone metabolism in male albino Wistar rats. Die Pharm. Int. J. Pharm. Sci. 66(8), 606\u2013610 (2011)","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"issue":"2","key":"1531_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4248\/ijos.08011","volume":"1","author":"C Liu","year":"2009","unstructured":"C. Liu, Z. Wu, H. Sun, The effect of simvastatin on mrna expression of transforming growth factor-\u03b21, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket. Int. J. Oral. Sci. 1(2), 90\u201398 (2009)","journal-title":"Int. J. Oral. Sci."},{"issue":"7","key":"1531_CR17","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jbmr.42","volume":"25","author":"W Wang","year":"2010","unstructured":"W. Wang, J.S. Nyman, H.E. Moss, G. Gutierrez, G.R. Mundy, X. Yang, F. Elefteriou, Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. J. Bone Mineral. Res. 25(7), 1658\u20131667 (2010)","journal-title":"J. Bone Mineral. Res."},{"issue":"2","key":"1531_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/08977194.2015.1011270","volume":"33","author":"JP Issa","year":"2015","unstructured":"J.P. Issa, C. Ingraci de Lucia, B.G. Dos Santos Kotake, M. Goncalves Gonzaga, F.A. Tocchini de Figueiredo, D. Mizusaki Iyomasa, A.P. Macedo, E. Ervolino, The effect of simvastatin treatment on bone repair of femoral fracture in animal model. Growth Factors 33(2), 139\u2013148 (2015)","journal-title":"Growth Factors"},{"issue":"3","key":"1531_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1600-0501.2003.01015.x","volume":"15","author":"Y Ayukawa","year":"2004","unstructured":"Y. Ayukawa, A. Okamura, K. Koyano, Simvastatin promotes osteogenesis around titanium implants. Clin. Oral. Implant. Res. 15(3), 346\u2013350 (2004)","journal-title":"Clin. Oral. Implant. Res."},{"issue":"12","key":"1531_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115595","volume":"9","author":"NI Ibrahim","year":"2014","unstructured":"N.I. Ibrahim, M.F. Khamis, M.F.M. Yunoh, S. Abdullah, N. Mohamed, A.N. Shuid, Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation. PloS. One 9(12), e115595 (2014)","journal-title":"PloS. One"},{"issue":"4","key":"1531_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.bone.2009.12.023","volume":"46","author":"S Chuengsamarn","year":"2010","unstructured":"S. Chuengsamarn, S. Rattanamongkoulgul, S. Suwanwalaikorn, S. Wattanasirichaigoon, L. Kaufman, Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone 46(4), 1011\u20131015 (2010)","journal-title":"Bone"},{"issue":"1","key":"1531_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1507\/endocrj.K06-127","volume":"54","author":"T Majima","year":"2007","unstructured":"T. Majima, Y. Komatsu, A. Fukao, K. Ninomiya, T. Matsumura, K. Nakao, Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr. J. 54(1), 145\u2013151 (2007)","journal-title":"Endocr. J."},{"issue":"7","key":"1531_CR23","first-page":"535","volume":"66","author":"B Chang","year":"2011","unstructured":"B. Chang, J. Yang, H. Li, S. Lu, L. Chen, P. Fang, Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats. Die Pharm. 66(7), 535\u2013537 (2011)","journal-title":"Die Pharm."},{"issue":"2","key":"1531_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12020-013-9924-z","volume":"44","author":"K Esposito","year":"2013","unstructured":"K. Esposito, A. Capuano, L. Sportiello, A. Giustina, D. Giugliano, Should we abandon statins in the prevention of bone fractures? Endocrine 44(2), 326\u2013333 (2013)","journal-title":"Endocrine"},{"issue":"10","key":"1531_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/hq1001.097781","volume":"21","author":"FJ Maritz","year":"2001","unstructured":"F.J. Maritz, M.M. Conradie, P.A. Hulley, R. Gopal, S. Hough, Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler. Thromb. Vasc. Biol. 21(10), 1636\u20131641 (2001)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"1531_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1211\/jpp.58.11.0005","volume":"58","author":"SB Jadhav","year":"2006","unstructured":"S.B. Jadhav, P.S. Narayana Murthy, M.M. Singh, G.K. Jain, Distribution of lovastatin to bone and its effect on bone turnover in rats. J. Pharm. Pharmacol. 58(11), 1451\u20131458 (2006)","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"1531_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2485\/jhtb.22.461","volume":"22","author":"R Ogasawara","year":"2013","unstructured":"R. Ogasawara, Y. Furuya, H. Sasaki, M. Yoshinari, Y. Yajima, Effects of oral administration of simvastatin on bone formation in senile osteoporosis rat. J. Hard Tissue Biol. 22(4), 461\u2013472 (2013)","journal-title":"J. Hard Tissue Biol."},{"issue":"9","key":"1531_CR28","first-page":"605","volume":"9","author":"M Thapar","year":"2013","unstructured":"M. Thapar, M.W. Russo, H.L. Bonkovsky, Statins and Liver Injury. Gastroenterol. Hepatol. 9(9), 605\u2013606 (2013)","journal-title":"Gastroenterol. Hepatol."},{"issue":"1","key":"1531_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/00498250802585539","volume":"39","author":"J Sidaway","year":"2009","unstructured":"J. Sidaway, Y. Wang, A.M. Marsden, T.C. Orton, F.R. Westwood, C.T. Azuma, R.C. Scott, Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy. Xenobiotica 39(1), 90\u201398 (2009)","journal-title":"Xenobiotica"},{"issue":"6","key":"1531_CR30","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1016\/j.actbio.2013.02.002","volume":"9","author":"V Alt","year":"2013","unstructured":"V. Alt, U. Thormann, S. Ray, D. Zahner, L. D\u00fcrselen, K. Lips, T. El Khassawna, C. Heiss, A. Riedrich, G. Schlewitz, A. Ignatius, M. Kampschulte, H. von Dewitz, S. Heinemann, R. Schnettler, A. Langheinrich, A new metaphyseal bone defect model in osteoporotic rats to study biomaterials for the enhancement of bone healing in osteoporotic fractures. Acta Biomater. 9(6), 7035\u20137042 (2013)","journal-title":"Acta Biomater."},{"key":"1531_CR31","doi-asserted-by":"crossref","unstructured":"X. Xu, H. Chen, X. Zhang, Z. Zhai, X. Liu, A. Qin, E. Lu, Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy. J. Transl. Med. 12, 284 (2014) https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4192445\/","DOI":"10.1186\/s12967-014-0284-0"},{"key":"1531_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2147\/DDDT.S133020","volume":"11","author":"N El-Nabarawi","year":"2017","unstructured":"N. El-Nabarawi, M. El-Wakd, M. Salem, Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study. Drug. Des. Dev. Ther. 11, 1383\u20131391 (2017)","journal-title":"Drug. Des. Dev. Ther."},{"key":"1531_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bone.2014.02.010","volume":"63","author":"A Oryan","year":"2014","unstructured":"A. Oryan, A. Bigham-Sadegh, F. Abbasi-Teshnizi, Effects of osteogenic medium on healing of the experimental critical bone defect in a rabbit model. Bone 63, 53\u201360 (2014)","journal-title":"Bone"},{"issue":"1","key":"1531_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12020-014-0292-0","volume":"48","author":"M Yamauchi","year":"2015","unstructured":"M. Yamauchi, T. Yamaguchi, K. Nawata, K.-i Tanaka, S. Takaoka, T. Sugimoto, Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women. Endocrine 48(1), 279\u2013286 (2015)","journal-title":"Endocrine"},{"key":"1531_CR35","doi-asserted-by":"crossref","unstructured":"Z. Wang, Y. Li, F. Zhou, Z. Piao, J. Hao, Effects of statins on bone mineral density and fracture risk: A Prisma-compliant systematic review and meta-analysis. Medicine 95(22), e3042 (2016) https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4900696\/","DOI":"10.1097\/MD.0000000000003042"},{"key":"1531_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-59745-104-8_8","volume":"455","author":"YP Kharode","year":"2008","unstructured":"Y.P. Kharode, M.C. Sharp, P.V. Bodine, Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. Osteoporosisc 455, 111\u2013124 (2008)","journal-title":"Osteoporosisc"},{"issue":"Supplement C","key":"1531_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jobaz.2015.04.007","volume":"72","author":"MM Elkomy","year":"2015","unstructured":"M.M. Elkomy, F.G. Elsaid, Anti-osteoporotic effect of medical herbs and calcium supplementation on ovariectomized rats. J. Basic Appl. Zool. 72(Supplement C), 81\u201388 (2015)","journal-title":"J. Basic Appl. Zool."},{"issue":"5","key":"1531_CR38","first-page":"424","volume":"58","author":"PP Lelovas","year":"2008","unstructured":"P.P. Lelovas, T.T. Xanthos, S.E. Thoma, G.P. Lyritis, I.A. Dontas, The laboratory rat as an animal model for osteoporosis research. Comp. Med. 58(5), 424\u2013430 (2008)","journal-title":"Comp. Med."},{"issue":"1","key":"1531_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/nsr\/nwu028","volume":"2","author":"SR Shah","year":"2015","unstructured":"S.R. Shah, C.A. Werlang, F.K. Kasper, A.G. Mikos, Novel applications of statins for bone regeneration. Natl. Sci. Rev. 2(1), 85\u201399 (2015)","journal-title":"Natl. Sci. Rev."},{"issue":"9","key":"1531_CR40","first-page":"e485","volume":"14","author":"JB Park","year":"2009","unstructured":"J.B. Park, The use of simvastatin in bone regeneration. Med. Oral. Patol. Oral. Cir. Bucal 14(9), e485\u2013e488 (2009)","journal-title":"Med. Oral. Patol. Oral. Cir. Bucal"},{"issue":"2","key":"1531_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1385\/ENDO:24:2:121","volume":"24","author":"T Kawane","year":"2004","unstructured":"T. Kawane, S. Terashima, I. Kurahashi, T. Yanagawa, H. Yoshida, N. Horiuchi, Atorvastatin enhances bone density in ovariectomized rats given 17\u03b2-estradiol or human parathyroid hormone (1\u201334). Endocrine 24(2), 121\u2013129 (2004)","journal-title":"Endocrine"},{"issue":"12","key":"1531_CR42","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1210\/jc.2006-1909","volume":"92","author":"HG Bone","year":"2007","unstructured":"H.G. Bone, D.P. Kiel, R.S. Lindsay, E.M. Lewiecki, M.A. Bolognese, E.T. Leary, W. Lowe, M.R. McClung, Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. J. Clin. Endocrinol. Metab. 92(12), 4671\u20134677 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1531_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.maturitas.2009.03.018","volume":"63","author":"Y Uyar","year":"2009","unstructured":"Y. Uyar, Y. Baytur, U. Inceboz, B.C. Demir, G. Gumuser, K. Ozbilgin, Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Maturitas 63(3), 261\u2013267 (2009)","journal-title":"Maturitas"},{"issue":"6","key":"1531_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00223-015-9975-7","volume":"96","author":"S Lin","year":"2015","unstructured":"S. Lin, J. Huang, Z. Fu, Y. Liang, H. Wu, L. Xu, Y. Sun, W.Y. Lee, T. Wu, L. Qin, The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats. Calcif. Tissue Int. 96(6), 541\u2013551 (2015)","journal-title":"Calcif. Tissue Int."},{"issue":"1-3","key":"1531_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2012.01.014","volume":"679","author":"I Gradosova","year":"2012","unstructured":"I. Gradosova, H. Zivna, V. Palicka, S. Hubena, K. Svejkovska, P. Zivny, Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats. Eur. J. Pharmacol. 679(1-3), 144\u2013150 (2012)","journal-title":"Eur. J. Pharmacol."},{"key":"1531_CR46","doi-asserted-by":"crossref","unstructured":"S. Abdul-Majeed, N. Mohamed, I.-N. Soelaiman, Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis. Evidence-Based Complementary and Alternative Medicine 2012, ID 960742 (2012) https:\/\/www.hindawi.com\/journals\/ecam\/2012\/960742\/","DOI":"10.1155\/2012\/960742"},{"issue":"1","key":"1531_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00198-016-3844-8","volume":"28","author":"T An","year":"2017","unstructured":"T. An, J. Hao, S. Sun, R. Li, M. Yang, G. Cheng, M. Zou, Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos. Int. 28(1), 47\u201357 (2017)","journal-title":"Osteoporos. Int."},{"issue":"5","key":"1531_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10059-011-0107-6","volume":"32","author":"LJ Qiao","year":"2011","unstructured":"L.J. Qiao, K.L. Kang, J.S. Heo, Simvastatin promotes osteogenic differentiation of mouse embryonic stem cells via canonical Wnt\/\u03b2-catenin signaling. Mol. Cells 32(5), 437\u2013444 (2011)","journal-title":"Mol. Cells"},{"issue":"11","key":"1531_CR49","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/jbmr.163","volume":"25","author":"J Pagkalos","year":"2010","unstructured":"J. Pagkalos, J.M. Cha, Y. Kang, M. Heliotis, E. Tsiridis, A. Mantalaris, Simvastatin induces osteogenic differentiation of murine embryonic stem cells. J. Bone Mineral. Res. 25(11), 2470\u20132478 (2010)","journal-title":"J. Bone Mineral. Res."},{"issue":"5","key":"1531_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5001\/omj.2014.93","volume":"29","author":"J Jose","year":"2014","unstructured":"J. Jose, F.A.A. Al-Tamimi, M.M. Helal, B. Jimmy, Q. Al Riyami, Statin associated associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman. Oman Med. J. 29(5), 351\u2013357 (2014)","journal-title":"Oman Med. J."},{"issue":"3","key":"1531_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151587","volume":"11","author":"AT Clarke","year":"2016","unstructured":"A.T. Clarke, P.C. Johnson, G.C. Hall, I. Ford, P.R. Mills, High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS. One 11(3), e0151587 (2016)","journal-title":"PLoS. One"},{"issue":"Supplement C","key":"1531_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tox.2016.06.015","volume":"359\u2013360","author":"SO El-Ganainy","year":"2016","unstructured":"S.O. El-Ganainy, A. El-Mallah, D. Abdallah, M.M. Khattab, M.M. Mohy El-Din, A.S. El-Khatib, Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model. Toxicology 359\u2013360(Supplement C), 29\u201338 (2016)","journal-title":"Toxicology"},{"issue":"4","key":"1531_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40520-014-0296-x","volume":"27","author":"K Mukaiyama","year":"2015","unstructured":"K. Mukaiyama, M. Kamimura, S. Uchiyama, S. Ikegami, Y. Nakamura, H. Kato, Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover. Aging Clin. Exp. Res. 27(4), 413\u2013418 (2015)","journal-title":"Aging Clin. Exp. Res."},{"issue":"1","key":"1531_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00198-015-3356-y","volume":"27","author":"HA Fink","year":"2016","unstructured":"H.A. Fink, S. Litwack-Harrison, B.C. Taylor, D.C. Bauer, E.S. Orwoll, C.G. Lee, E. Barrett-Connor, J.T. Schousboe, D.M. Kado, P.S. Garimella, K.E. Ensrud, Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos. Int. 27(1), 331\u2013338 (2016)","journal-title":"Osteoporos. Int."},{"issue":"8","key":"1531_CR55","doi-asserted-by":"publisher","first-page":"Cr442","DOI":"10.12659\/MSM.881905","volume":"17","author":"A Panico","year":"2011","unstructured":"A. Panico, G.A. Lupoli, F. Marciello, R. Lupoli, M. Cacciapuoti, A. Martinelli, L. Granieri, D. Iacono, G. Lupoli, Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life. Med. Sci. Monit. 17(8), Cr442\u2013Cr448 (2011)","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"1531_CR56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMp1106689","volume":"365","author":"A Egan","year":"2011","unstructured":"A. Egan, E. Colman, Weighing the benefits of high-dose simvastatin against the risk of myopathy. New Engl. J. Med. 365(4), 285\u2013287 (2011)","journal-title":"New Engl. J. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1531-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T16:47:04Z","timestamp":1570639624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1531-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1531-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}